When a compound has no completed human trial, there is by definition no safety data in any subgroup no pregnancy data, no hepatic-impairment data, no interaction data with common metabolic or endocrine medications
recommended daily allowance (RDA) is: 2.4 micrograms (mcg) per day Certain groups may require higher intake, including: Pregnant women: 2.6 mcg daily Breastfeeding women: 2.8 mcg daily Older adults Vegetarians and vegans Individuals with absorption issues 500 mcg to 5000 mcg , which is significantly higher than the RDA but still generally considered safe when medically supervised
Timing is Key: Administer the daily dose first thing in the morning
The peptide contains an internal disulfide bond between the two cysteine residues, which is critical for its three-dimensional conformation
Full thymosin beta-4 is a 43-residue molecule with additional active regions
What Is Peptide Therapy and Is It Safe